In this issue:
Difelikefalin for notalgia paraesthetica
Dupilumab for erythrodermic AD
Association of lipid-lowering drugs with psoriasis risk
Cutaneous manifestations of SARS-COV-2 during delta and omicron waves
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events
Tralokinumab improves skin microbiota in moderate-to-severe AD
Isotretinoin and inflammatory bowel disease/irritable bowel syndrome risk
Single-dose, patient-initiated amenamevir for recurrent herpes labialis
Topical calcipotriol for cutaneous warts
Please login below to download this issue (PDF)